These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9333262)

  • 21. Higher antiviral activity of antiretroviral regimens including protease inhibitors.
    de Mendoza C; Soriano V; Rodríguez-Rosado R; González-Lahoz J
    AIDS; 1999 May; 13(8):998-9. PubMed ID: 10371186
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV drug now approved for use with protease inhibitors.
    Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335
    [No Abstract]   [Full Text] [Related]  

  • 23. Limited use for dual treatment with boosted protease inhibitors plus lamivudine in first-line antiretroviral therapy.
    Orrell C; Kaplan R
    Lancet Infect Dis; 2015 Jul; 15(7):748-9. PubMed ID: 26062879
    [No Abstract]   [Full Text] [Related]  

  • 24. [HIV-treatment. Interactions, compliance, prolonged adverse effects and global accessibility].
    Gerstoft J
    Ugeskr Laeger; 2000 Aug; 162(35):4639. PubMed ID: 10986887
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV-protease inhibitors.
    Flexner C
    N Engl J Med; 1998 Apr; 338(18):1281-92. PubMed ID: 9562584
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply: Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients.
    Fätkenheuer G; Rockstroh J; Salzberger B
    AIDS; 1998 Jul; 12(11):1402-3. PubMed ID: 9708429
    [No Abstract]   [Full Text] [Related]  

  • 27. Tipranavir in the protease inhibitors arena.
    Vergani B; Rusconi S
    Drugs R D; 2011 Dec; 11(4):291-3. PubMed ID: 22133386
    [No Abstract]   [Full Text] [Related]  

  • 28. What's new in HIV.
    Morris-Jones S; Nelson MR
    J Infect; 1999 Mar; 38(2):i-ii. PubMed ID: 10342641
    [No Abstract]   [Full Text] [Related]  

  • 29. Protease inhibitor-sparing regimens.
    Smith KY
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):116-20. PubMed ID: 12942669
    [No Abstract]   [Full Text] [Related]  

  • 30. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
    Merry C; Mulcahy F; Barry M; Gibbons S; Back D
    AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
    [No Abstract]   [Full Text] [Related]  

  • 31. Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran.
    Kakadiya PP; Higginson RT; Fulco PP
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133562
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor.
    Lisziewicz J; Jessen H; Finzi D; Siliciano RF; Lori F
    Lancet; 1998 Jul; 352(9123):199-200. PubMed ID: 9683211
    [No Abstract]   [Full Text] [Related]  

  • 33. Scientific considerations for pharmacoenhancers in antiretroviral therapy.
    Arya V; Robertson SM; Struble KA; Murray JS
    J Clin Pharmacol; 2012 Aug; 52(8):1128-33. PubMed ID: 21712496
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiretroviral treatment in 1999: from uncertainty to hopefulness].
    Pujol de la Llave E
    An Med Interna; 1999 May; 16(5):215-7. PubMed ID: 10389304
    [No Abstract]   [Full Text] [Related]  

  • 36. Rebound of HIV-1 viral load after suppression to very low levels.
    Staszewski S; Miller V; Sabin C; Berger A; Hill AM; Phillips AN
    AIDS; 1998 Dec; 12(17):2360. PubMed ID: 9863886
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination antiretroviral therapy.
    McKinney RE
    Pediatr Infect Dis J; 1998 Jun; 17(6):515-6. PubMed ID: 9655545
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled trial of double versus triple therapy for HIV.
    Delgado Fernández M; Zambrana García JL; Díez García F
    N Engl J Med; 1998 Jan; 338(3):197. PubMed ID: 9441226
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy.
    Mastroianni CM; Trinchieri V; Santopadre P; Lichtner M; Forcina G; D'Agostino C; Corpolongo A; Vullo V
    AIDS; 1998 Oct; 12(14):1939-40. PubMed ID: 9792403
    [No Abstract]   [Full Text] [Related]  

  • 40. ABT-378 lowers viral load.
    AIDS Patient Care STDS; 1999 Mar; 13(3):199. PubMed ID: 10375268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.